The 38th Asia Pacific Academy of Ophthalmology (APAO) Congress was a truly remarkable event that took place from 23-26 Feb 2023 in Kuala Lumpur. It was a great pleasure to see ophthalmologists, researchers, and innovators from all over the world come together to exchange their knowledge and experiences in the field of ophthalmology. The congress was not only informative, but it also provided an excellent platform for networking, learning, and collaborating.

The success of this event would not have been possible without the support of our partners, Moptim, Frey, and Visionix. Their contribution was invaluable, and we extend our heartfelt gratitude to them for being part of this incredible journey. One of the highlights of the congress was the exhibition, where various innovative products and technologies were showcased.

The Visionix Vx120+ with dry eye is a multiple diagnostic system that can screen and monitor eye pathologies, including dry eye syndromes. It is an excellent tool that enables early detection and management of dry eye, a common condition that affects a significant portion of the population.

The Moptim Mocean 4000 SLO-OCT is a spectral domain OCT that combines OCT angiography, posterior and anterior OCT to aid the diagnosis of retinal and glaucoma conditions. Its high resolution and accuracy make it an indispensable tool in the management of retinal and glaucoma diseases.

The Frey SL-100 Digital slit lamp is an advanced LED slit lamp microscope that is designed for high performance, accurate diagnosis, reliability, and patient comfort. Its brilliant optics result in stunning image quality and resolution, making it an ideal tool for assessing the anterior segment of the eye.

In conclusion, the 38th Asia Pacific Academy of Ophthalmology Congress was an unforgettable experience that brought together some of the brightest minds in the field of ophthalmology. The contributions of our partners, Moptim, Frey, and Visionix, were crucial in making this event a success. We look forward to future collaborations and continuing our efforts to advance the field of ophthalmology.